Putative Immunodominant Human Immunodeficiency Virus-Specific CD8<sup>+</sup>T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I HaplotypeMichael R. Betts, Richard A. Koup, Wendy L. Trigona et al.|Journal of Virology|2000Cited by 150
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trialsMyra Happe, Jamie Sanders, Amelia R. Hofstetter et al.|npj Vaccines|2024Cited by 19